IPN-60090
N/A
Report date: 2023/10/20 20:06:50
NME
Base Information
Drug NameIPN-60090
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[9]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIpsenThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A
Develop Information
Active CompaniesThe University Of Texas MD Anderson Cancer Center
Inactive CompaniesIpsen
Active Indications +[9]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A